These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 22958221

  • 21. Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Kato H, Miyakawa Y, Hidaka Y, Inoue N, Ito S, Kagami S, Kaname S, Matsumoto M, Mizuno M, Matsuda T, Shimono A, Maruyama S, Fujimura Y, Nangaku M, Okada H.
    Clin Exp Nephrol; 2019 Jan; 23(1):65-75. PubMed ID: 29959568
    [Abstract] [Full Text] [Related]

  • 22. Anti-C5 monoclonal antibody treatment showing pathological resolution of complement-mediated atypical hemolytic uremic syndrome: a case report.
    Kurihara S, Yamaguchi A, Sonoda K, Yamada Y, Harada M, Hashimoto K, Shimojo H, Ikeda Y, Kamijo Y.
    BMC Nephrol; 2024 Jul 15; 25(1):224. PubMed ID: 39009967
    [Abstract] [Full Text] [Related]

  • 23. Outcome of atypical hemolytic uremic syndrome: role of triggers and complement abnormalities in the response to C5 inhibition.
    Ardissino G, Cresseri D, Mancuso MC, Capone V, Porcaro L, Amico V, Tangredi M, Grovetti E, Griffini S, Castellano G, Montini G, Consonni D, Cugno M, HUS-ItalKid Network..
    J Nephrol; 2024 May 15; 37(4):1017-1026. PubMed ID: 38280096
    [Abstract] [Full Text] [Related]

  • 24. Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy.
    Fakhouri F, Frémeaux-Bacchi V, Loirat C.
    Eur J Intern Med; 2013 Sep 15; 24(6):492-5. PubMed ID: 23756030
    [Abstract] [Full Text] [Related]

  • 25. Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions.
    Békássy ZD, Kristoffersson AC, Cronqvist M, Roumenina LT, Rybkine T, Vergoz L, Hue C, Fremeaux-Bacchi V, Karpman D.
    Nephrol Dial Transplant; 2013 Nov 15; 28(11):2899-907. PubMed ID: 24009284
    [Abstract] [Full Text] [Related]

  • 26. Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use.
    Wijnsma KL, Duineveld C, Wetzels JFM, van de Kar NCAJ.
    Pediatr Nephrol; 2019 Nov 15; 34(11):2261-2277. PubMed ID: 30402748
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome.
    Lapeyraque AL, Frémeaux-Bacchi V, Robitaille P.
    Pediatr Nephrol; 2011 Apr 15; 26(4):621-4. PubMed ID: 21161283
    [Abstract] [Full Text] [Related]

  • 31. Atypical hemolytic uremic syndrome.
    Loirat C, Frémeaux-Bacchi V.
    Orphanet J Rare Dis; 2011 Sep 08; 6():60. PubMed ID: 21902819
    [Abstract] [Full Text] [Related]

  • 32. Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.
    Mallett A, Hughes P, Szer J, Tuckfield A, Van Eps C, Cambell SB, Hawley C, Burke J, Kausman J, Hewitt I, Parnham A, Ford S, Isbel N.
    Intern Med J; 2015 Oct 08; 45(10):1054-65. PubMed ID: 26247170
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
    Tran H, Chaudhuri A, Concepcion W, Grimm PC.
    Pediatr Nephrol; 2014 Mar 08; 29(3):477-80. PubMed ID: 24221349
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome.
    Weitz M, Amon O, Bassler D, Koenigsrainer A, Nadalin S.
    Pediatr Nephrol; 2011 Aug 08; 26(8):1325-9. PubMed ID: 21556717
    [Abstract] [Full Text] [Related]

  • 39. Eculizumab long-term therapy for pediatric renal transplant in aHUS with CFH/CFHR1 hybrid gene.
    Román-Ortiz E, Mendizabal Oteiza S, Pinto S, López-Trascasa M, Sánchez-Corral P, Rodríguez de Cordoba S.
    Pediatr Nephrol; 2014 Jan 08; 29(1):149-53. PubMed ID: 23982707
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.